{"id":"W2051243940","doi":"10.1111/dom.12188","title":"Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Empagliflozin; Metformin; Pioglitazone; Placebo; Medicine; Type 2 diabetes; Tolerability; Internal medicine; Clinical endpoint; Urology; Diabetes mellitus; Adverse effect; Randomized controlled trial; Gastroenterology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002052417,0.001333539,0.003151659,0.000509139,0.0003812845,0.00103002,0.0008753542,0.001947168,0.004433277],"category_scores_gemma":[0.002026622,0.0006929382,0.002106684,0.0004331471,0.0008990005,0.0008308422,0.0003820977,0.002825375,0.0005097526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004752351,"about_ca_system_score_gemma":0.0006838581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005549997,"about_ca_topic_score_gemma":0.001174836,"domain_scores_codex":[0.9991524,0.0004686044,0.00008272652,0.0001233944,0.00008856288,0.00008420769],"domain_scores_gemma":[0.998982,0.0003460714,0.0002548942,0.00007629394,0.00006065965,0.0002801142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9788154,0.005825591,0.0006747583,0.0005680133,0.001182567,0.00003341175,0.00002283831,0.0001141367,0.001297334,0.00002312941,0.0002192403,0.0112236],"study_design_scores_gemma":[0.9510817,0.04525707,0.002097957,0.00003164063,0.0007258956,0.00002392803,0.000009741275,0.0002036462,0.0003399623,0.00002629211,0.0001943981,0.000007813163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98984,0.005763136,0.0003866114,0.0003798528,0.0005546584,0.001518423,0.0004084632,0.00009333753,0.001055526],"genre_scores_gemma":[0.9902352,0.003890292,0.0009061033,0.0007845564,0.0007693542,0.001644548,0.0005047938,0.00001472048,0.001250586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004433277,"threshold_uncertainty_score":0.01483077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006671166235841569,"score_gpt":0.2134640705234327,"score_spread":0.2067929042875911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}